Sumitomo Mitsui Ds Asset Management Company, LTD Eli Lilly & CO Transaction History

Sumitomo Mitsui Ds Asset Management Company, LTD

  • $9.15 Billion
  • Q3 2024

A detailed history of Sumitomo Mitsui Ds Asset Management Company, LTD transactions in Eli Lilly & CO stock. As of the latest transaction made, Sumitomo Mitsui Ds Asset Management Company, LTD holds 121,496 shares of LLY stock, worth $96.7 Million. This represents 1.18% of its overall portfolio holdings.

Number of Shares
121,496
Previous 118,394 2.62%
Holding current value
$96.7 Million
Previous $107 Million 0.42%
% of portfolio
1.18%
Previous 1.28%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024
BUY
$772.14 - $960.02 $2.4 Million - $2.98 Million
3,102 Added 2.62%
121,496 $108 Million
Q2 2024

Jul 30, 2024
BUY
$724.87 - $909.04 $1.8 Million - $2.26 Million
2,481 Added 2.14%
118,394 $107 Million
Q1 2024

May 02, 2024
BUY
$592.2 - $792.28 $1.18 Million - $1.57 Million
1,986 Added 1.74%
115,913 $90.2 Million
Q4 2023

Feb 01, 2024
BUY
$525.19 - $619.13 $402,820 - $474,872
767 Added 0.68%
113,927 $66.4 Million
Q3 2023

Oct 30, 2023
BUY
$434.7 - $599.3 $1.83 Million - $2.52 Million
4,210 Added 3.86%
113,160 $60.8 Million
Q2 2023

Aug 04, 2023
BUY
$350.74 - $468.98 $7.49 Million - $10 Million
21,341 Added 24.36%
108,950 $51.1 Million
Q1 2023

May 02, 2023
BUY
$310.63 - $364.82 $917,911 - $1.08 Million
2,955 Added 3.49%
87,609 $30.1 Million
Q4 2022

Jan 26, 2023
BUY
$321.55 - $374.67 $1.03 Million - $1.2 Million
3,208 Added 3.94%
84,654 $0
Q3 2022

Oct 19, 2022
SELL
$296.48 - $337.87 $383,348 - $436,865
-1,293 Reduced 1.56%
81,446 $26.3 Million
Q2 2022

Jul 13, 2022
SELL
$278.73 - $327.27 $1.1 Million - $1.3 Million
-3,963 Reduced 4.57%
82,739 $26.8 Million
Q1 2022

Apr 19, 2022
BUY
$234.69 - $291.66 $186,343 - $231,578
794 Added 0.92%
86,702 $24.8 Million
Q4 2021

Jan 20, 2022
SELL
$224.85 - $279.04 $150,649 - $186,956
-670 Reduced 0.77%
85,908 $23.7 Million
Q3 2021

Oct 15, 2021
SELL
$221.6 - $272.71 $215,173 - $264,801
-971 Reduced 1.11%
86,578 $20 Million
Q2 2021

Jul 19, 2021
BUY
$180.55 - $233.54 $1.53 Million - $1.97 Million
8,453 Added 10.69%
87,549 $20.1 Million
Q1 2021

May 07, 2021
SELL
$164.32 - $212.72 $281,644 - $364,602
-1,714 Reduced 2.12%
79,096 $14.8 Million
Q4 2020

Feb 02, 2021
SELL
$130.46 - $172.63 $1.01 Million - $1.34 Million
-7,767 Reduced 8.77%
80,810 $13.6 Million
Q3 2020

Oct 29, 2020
BUY
$146.22 - $169.13 $406,637 - $470,350
2,781 Added 3.24%
88,577 $13.1 Million
Q2 2020

Aug 12, 2020
BUY
$136.42 - $164.18 $1.77 Million - $2.13 Million
12,977 Added 17.82%
85,796 $14.1 Million
Q1 2020

Apr 21, 2020
SELL
$119.05 - $147.35 $2,500 - $3,094
-21 Reduced 0.03%
72,819 $10.1 Million
Q4 2019

Jan 24, 2020
BUY
$106.92 - $132.43 $1.7 Million - $2.11 Million
15,903 Added 27.93%
72,840 $9.57 Million
Q3 2019

Oct 16, 2019
BUY
$106.79 - $116.16 $447,877 - $487,175
4,194 Added 7.95%
56,937 $6.37 Million
Q2 2019

Aug 13, 2019
SELL
$110.79 - $129.32 $1.34 Million - $1.56 Million
-12,052 Reduced 18.6%
52,743 $5.84 Million
Q1 2019

May 07, 2019
SELL
$111.31 - $131.02 $350,626 - $412,713
-3,150 Reduced 4.64%
64,795 $8.41 Million
Q4 2018

Jan 25, 2019
SELL
$105.9 - $118.64 $438,108 - $490,813
-4,137 Reduced 5.74%
67,945 $7.86 Million
Q3 2018

Oct 15, 2018
SELL
$85.86 - $107.31 $47,738 - $59,664
-556 Reduced 0.77%
72,082 $7.74 Million
Q2 2018

Jul 31, 2018
SELL
$75.7 - $86.88 $8,024 - $9,209
-106 Reduced 0.15%
72,638 $6.2 Million
Q1 2018

Apr 25, 2018
BUY
$74.21 - $87.6 $96,547 - $113,967
1,301 Added 1.82%
72,744 $5.63 Million
Q4 2017

Jan 25, 2018
SELL
$81.94 - $87.89 $343,574 - $368,522
-4,193 Reduced 5.54%
71,443 $6.03 Million
Q3 2017

Oct 27, 2017
BUY
$77.07 - $85.54 $5.83 Million - $6.47 Million
75,636
75,636 $6.47 Million

Others Institutions Holding LLY

# of Institutions
4,011
Shares Held
751M
Call Options Held
8.27M
Put Options Held
10.5M
View Full List

About ELI LILLY & Co

LLY Quotes by TradingView
  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Sumitomo Mitsui Ds Asset Management Company, LTD Portfolio

Follow Sumitomo Mitsui Ds Asset Management Company, LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Ds Asset Management Company, LTD, based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Mitsui Ds Asset Management Company, LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email